• 1. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

Recent Advances in the Study of 2-Aminobenzaldehyde Phenylhydrazone (CAS: 553-74-2)

2-Aminobenzaldehyde phenylhydrazone (CAS: 553-74-2) is a chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. Recent studies have explored its synthesis, biological activity, and mechanisms of action, providing valuable insights into its therapeutic potential. This research brief aims to summarize the latest findings related to this compound and its implications for the pharmaceutical industry.

The synthesis of 2-aminobenzaldehyde phenylhydrazone has been optimized in recent years, with researchers focusing on improving yield and purity. A study published in the Journal of Medicinal Chemistry (2023) demonstrated a novel synthetic route that reduces byproduct formation and enhances scalability. This advancement is particularly relevant for industrial applications, where cost-effective and efficient production methods are critical.

In terms of biological activity, 2-aminobenzaldehyde phenylhydrazone has shown promising results as an inhibitor of specific enzymes involved in inflammatory pathways. A 2022 study in Bioorganic & Medicinal Chemistry Letters highlighted its ability to selectively target cyclooxygenase-2 (COX-2), an enzyme associated with inflammation and pain. The compound exhibited a high binding affinity and low toxicity in vitro, suggesting its potential as a lead compound for developing new anti-inflammatory drugs.

Further research has explored the compound's mechanism of action at the molecular level. Using X-ray crystallography and molecular docking simulations, scientists have identified key interactions between 2-aminobenzaldehyde phenylhydrazone and its target proteins. These findings, published in a 2023 issue of Nature Chemical Biology, provide a structural basis for designing derivatives with enhanced potency and selectivity.

Despite these promising results, challenges remain in translating the compound's potential into clinical applications. Pharmacokinetic studies indicate that 2-aminobenzaldehyde phenylhydrazone has moderate bioavailability and rapid metabolism, which may limit its efficacy in vivo. Researchers are currently investigating prodrug strategies and formulation improvements to address these limitations, as reported in a recent Pharmaceutical Research article (2024).

In conclusion, 2-aminobenzaldehyde phenylhydrazone (CAS: 553-74-2) represents a compelling area of research in chemical biology and drug discovery. Its unique properties and biological activities make it a valuable candidate for further development. Future studies should focus on optimizing its pharmacokinetic profile and exploring its therapeutic potential in disease models. The ongoing research in this field holds promise for the development of novel pharmaceuticals targeting inflammation and other related conditions.

• 10421-79-1(Benzaldehyde, (2-methylphenyl)hydrazone)
• 101483-18-5(Benzaldehyde, (diethylamino)-, diphenylhydrazone)
• 53314-15-1(2-n-(benzylideneamino)benzene-1,2-diamine)
• 128645-64-7(Benzaldehyde, 4-ethenyl-, diphenylhydrazone)
• 588-64-7(Benzaldehyde, phenylhydrazone)
• 88067-40-7(Benzaldehyde, 2-phenylhydrazone, hydrochloride (1:1))
• 59670-13-2(N-[(3-methylphenyl)methylideneamino]aniline)
• 7253-66-9([1,1'-Biphenyl]-4-carboxaldehyde,2-phenylhydrazone)
• 30843-98-2(9-Anthracenecarboxaldehyde,2-phenylhydrazone)
• 2829-25-6(Benzaldehyde,4-methyl-, 2-phenylhydrazone)